A Case Study of the Impact of Language Concordance on Patient Care, Satisfaction, and Comfort with Sharing Sensitive Information During Medical Care.
Alexandra Lopez Vera, Kyle Thomas, Christina Trinh...
https://pubmed.ncbi.nlm.nih.gov/36840903/Actively Recruiting
Led by Washington University School of Medicine · Updated on 2025-03-28
70
Participants Needed
1
Research Sites
13 weeks
Total Duration
Researchers are studying how language differences affect fertility treatment progress among Spanish-speaking patients. This study aims to find out if seeing a Spanish-speaking doctor leads to faster completion of necessary tests and starting treatments compared to using an interpreter with an English-speaking provider. The study is important because Spanish is the most common non-English language in the U.S., and it explores how language matching might improve fertility care outcomes. The study will take place over 12 months at a fertility center and will include 70 Spanish-speaking patients. Half will be randomly assigned to see English-speaking providers using interpreters, while the other half will see a Spanish-speaking provider. The medical tests and treatments will remain the same for all participants. Participants will also complete surveys about their satisfaction and communication experience in their preferred language. Participants will be followed for 90 days after their first visit to see how quickly they complete diagnostic tests and begin treatment. Researchers will collect survey responses to evaluate patient satisfaction and communication effectiveness. The studys main goal is to compare the timing of test completion and treatment start between the two groups. All procedures and treatments are monitored under standard clinical care during this period.
CONDITIONS
Language Matters: Exploring the Impact of Language Concordance on Fertility Treatment Progression
A
Aileen Portugal, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Washington University School of Medicine
Lead Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | Language‑concordant provider | Interpreter‑mediated standard care |
|---|---|---|
| What it is | Fertility treatment progression when Spanish‑speaking patients see a provider who speaks Spanish directly | Fertility treatment progression when Spanish‑speaking patients see an English‑speaking provider via interpreter |
| Role in the trial | Interventional arm evaluating language‑concordant provider care | Comparator arm representing standard interpreter‑mediated communication |
| Primary use or comparison | Assesses whether direct Spanish‑language communication accelerates fertility diagnostic completion and treatment initiation | Represents current standard communication method in fertility care for Spanish‑speaking patients using interpreter |
| How it is delivered | Patients are seen directly by a provider fluent in Spanish without interpreter use | Patients see an English‑speaking provider using interpreter services for communication |
| Evidence status beyond this trial | LANGUAGE‑concordant care generally improves patient trust and satisfaction in other health contexts | Interpreter‑mediated care is commonly used but may be associated with lower trust or communication quality compared with language‑concordant care |
| Important risks | No intervention‑specific safety risks, as this is a communication‑based approach | No additional safety risks identified for interpreter‑mediated care |
| Important limitations | Findings may not generalize beyond Spanish‑speaking patients or fertility settings | Results may not apply to settings with professional interpreter services or bilingual support availability |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 90 days from initial consultation
Participants receive fertility treatment consultations conducted by either Spanish-speaking or English-speaking providers using an interpreter.
1 initial consultation visit
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Alexandra Lopez Vera, Kyle Thomas, Christina Trinh...
https://pubmed.ncbi.nlm.nih.gov/36840903/Meaghan Jain, Andrea Peterson, Nadia Nguyen...
https://pubmed.ncbi.nlm.nih.gov/37225071/Terceira A Berdahl, James B Kirby
https://pubmed.ncbi.nlm.nih.gov/30511285/Washington University School of Medicine
Lead Sponsor